I didn't say Regen's possible secondary offering would be a $1 per share. I said it was historically $1 and the average biotech IPO this year is $5-$15 per share.
All of my posts about stocks I own are expressed consistently in one direction based on my own research and due diligence.
Feel free to check my history. Can you or those you listen to say the same?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.